Suresh Ramu – Co-founder & CEO - Cytecare Hospitals of Cytecare Hospitals
View Detailed Executive Profile →Professional Overview
- Suresh Ramu is the Co-founder and CEO of Cytecare Hospitals, a pioneering institution in India focused on providing organ-specific, patient-first cancer care, which began operations in April 2014.
- Under Suresh Ramu's leadership, Cytecare Hospitals launched its first facility in Bangalore in November 2016, a 150-bedded hospital that has since treated over 10,000 patients from India and more than 25 countries.
- Ramu has emphasized the importance of patient-centric care, ensuring that Cytecare Hospitals adheres to global standards and care protocols, which has contributed to its reputation as a respected name in cancer treatment both in India and internationally.
- In a reflection on the hospital's milestones, Suresh Ramu highlighted the organization's commitment to improving cancer care outcomes in India, showcasing the impact of their specialized services on patient health and recovery.
- Ramu's strategic vision includes creating a network of comprehensive cancer care hospitals across India, aiming to enhance accessibility and quality of treatment for patients.
- With a focus on clinical governance, Suresh Ramu has assembled a team of renowned organ-site focused cancer specialists, ensuring that patients receive expert care tailored to their specific needs.
- Ramu has been instrumental in fostering a values-based, performance-driven culture within Cytecare Hospitals, prioritizing quality, technology, and patient satisfaction in healthcare delivery.
- With over two decades of experience in healthcare delivery and clinical research, Suresh Ramu has worked on improving efficiencies and effectiveness within the clinical research industry, contributing to advancements in cancer treatment methodologies.
- Ramu's leadership has positioned Cytecare Hospitals as a leader in the healthcare sector, recognized for its innovative approaches to cancer care and commitment to patient outcomes.
- Through his entrepreneurial efforts, Suresh Ramu has played a significant role in transforming the landscape of cancer care in India, addressing the growing need for specialized treatment facilities.
- Ramu's dedication to improving healthcare delivery best practices is evident in Cytecare's operational strategies, which emphasize continuous improvement and adaptation to emerging healthcare challenges.
- As a senior management professional, Suresh Ramu has been involved in the setup and growth of various organizations, leveraging his expertise to drive success in the healthcare sector.
- Ramu's vision for Cytecare Hospitals includes not only expanding its physical presence but also enhancing the overall patient experience through innovative healthcare solutions.
- His commitment to quality and patient-centricity has led to the establishment of strong clinical governance frameworks within Cytecare, ensuring high standards of care are consistently met.
- Suresh Ramu continues to advocate for advancements in cancer care, positioning Cytecare Hospitals as a model for future healthcare initiatives in India and beyond.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Quintiles | Head - Technology, India | Sep 2002 – Apr 2003 |
| Quintiles | Senior Manager Operations, ECG Services | Oct 2001 – Sep 2002 |
| Quintiles Transnational | Vice President & Head - India, Clinical Development Services | Nov 2009 – Mar 2011 |
| Quintiles | Executive Director - Clinical Data Management | Nov 2005 – Mar 2008 |
| Ruksun DoctorAnywhere.com Pvt. Ltd, Pune | Product Manager & Management Representative | May 2000 – Sep 2001 |
| Larsen & Toubro Ltd, Mumbai | Engineer Trainee, International Sales, Gr II | Jul 1995 – Jun 1996 |
| Quintiles | Vice President - Global Data Management, Asia | Apr 2008 – Oct 2009 |
| Quintiles | Senior Director - Clinical Data Management | Apr 2003 – Oct 2005 |
| PricewaterhouseCoopers | Consultant, Process Improvement and Supply Chain Management | Apr 1998 – May 2000 |
| QUINTILES TECHNOLOGIES (INDIA) PRIVATE L IMITED | Director | 13-Feb-2004 – 31-Oct-2009 |
| CYTECARE HOSPITALS PRIVATE LIMITED | Director | 11-Mar-2014 – 22-May-2018 |
| EYESTEM RESEARCH PRIVATE LIMITED | Additional Director | 07-Nov-2017 – 30-Aug-2018 |
| IQVIA RDS (INDIA) PRIVATE LIMITED | Director | 01-Nov-2009 – 01-Nov-2010 |
| Cytecare Hospitals | Co-founder & CEO | Apr 2014 – Present |
| Cytespace Research Pvt Ltd | Co-founder and Director | Apr 2011 – Present |
| EYESTEM RESEARCH PRIVATE LIMITED | Director | 30-Aug-2018 – Present |
| CYTECARE HOSPITALS PRIVATE LIMITED | Director | 23-May-2018 – Present |
| CYTESPACE RESEARCH PRIVATE LIMITED | Director | 11-Mar-2011 – Present |
| BIO-COMBINATOR LLP | Partner | 06-Mar-2024 – Present |
Current Appointments
| CIN/LLP | Company | Designation | Date |
|---|---|---|---|
| ACF-9022 | BIO-COMBINATOR LLP | Partner | 06-Mar-2024 |
| U73100GJ2011PTC064350 | CYTESPACE RESEARCH PRIVATE LIMITED | Director | 11-Mar-2011 |
| U74999KA2015PTC164505 | EYESTEM RESEARCH PRIVATE LIMITED | Director | 30-Aug-2018 |
| U85110GJ2014PTC079078 | CYTECARE HOSPITALS PRIVATE LIMITED | Director | 23-May-2018 |
Previous Appointments
| CIN/LLP | Company | Designation | Period |
|---|---|---|---|
| U73100GJ2002PTC041630 | QUINTILES TECHNOLOGIES (INDIA) PRIVATE L IMITED | Director | 13-Feb-2004 – 31-Oct-2009 |
| U73100KA2002PTC107115 | IQVIA RDS (INDIA) PRIVATE LIMITED | Director | 01-Nov-2009 – 01-Nov-2010 |
| U74999KA2015PTC164505 | EYESTEM RESEARCH PRIVATE LIMITED | Additional Director | 07-Nov-2017 – 30-Aug-2018 |
| U85110GJ2014PTC079078 | CYTECARE HOSPITALS PRIVATE LIMITED | Director | 11-Mar-2014 – 22-May-2018 |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Cytecare Hospitals corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Suresh Ramu's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Cytecare Hospitals's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)